Tbx1 is a negative modulator of Mef2c

Human Molecular Genetics

Volumn 21, Issue 11, 2012, Pages 2485-2496

  Pane, Luna Simona ^a,b   Zhang, Zhen ^c   Ferrentino, Rosa ^a,b   Huynh, Tuong ^d   Cutillo, Luisa ^b,e   Baldini, Antonio ^a,b,f  

^a INSTITUTE OF GENETICS AND BIOPHYSICS ADRIANO BUZZATI TRAVERSO   (Italy)

^b TELETHON INSTITUTE OF GENETICS AND MEDICINE TIGEM   (Italy)

^c SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^d BAYLOR COLLEGE OF MEDICINE   (United States)

^e UNIVERSITY OF NAPLES PARTHENOPE   (Italy)

^f UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

T BOX TRANSCRIPTION FACTOR; T BOX TRANSCRIPTION FACTOR TBX1; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR GATA 4; TRANSCRIPTION FACTOR MEF2C; UNCLASSIFIED DRUG;

ALLELE; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; EMBRYO; EMBRYONAL TISSUE; GAIN OF FUNCTION MUTATION; GENE EXPRESSION; GENE LOCUS; IN VIVO STUDY; MALE; MICROARRAY ANALYSIS; MOUSE; MUSCLE DEVELOPMENT; MUTANT; NONHUMAN; PRIORITY JOURNAL; SKELETAL MUSCLE; SOMITE; STEM CELL; UPREGULATION; WILD TYPE;

ALLELES; ANIMALS; CELL DIFFERENTIATION; GENOTYPE; MICE; MICE, TRANSGENIC; MYOGENIC REGULATORY FACTORS; PHENOTYPE; T-BOX DOMAIN PROTEINS; TRANSCRIPTOME; TRANSFECTION; UP-REGULATION;

EID: 84861128913     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/dds063     Document Type: Article

References (46)

1. Yagi, H., Furutani, Y., Hamada, H., Sasaki, T., Asakawa, S., Minoshima, S., Ichida, F., Joo, K., Kimura, M., Imamura, S. et al. (2003) Role of TBX1 in human del22q11.2 syndrome. Lancet, 362, 1366-1373.
2. Stoller, J.Z. and Epstein, J.A. (2005) Identification of a novel nuclear localization signal in Tbx1 that is deleted in DiGeorge syndrome patients harboring the 1223delC mutation. Hum. Mol. Genet., 14, 885-892.
3. Paylor, R., Glaser, B., Mupo, A., Ataliotis, P., Spencer, C., Sobotka, A., Sparks, C., Choi, C.H., Oghalai, J., Curran, S. et al. (2006) Tbx1 haploinsufficiency is linked to behavioral disorders in mice and humans: implications for 22q11 deletion syndrome. Proc. Natl Acad. Sci. USA, 103, 7729-7734.
4. Torres-Juan, L., Rosell, J., Morla, M., Vidal-Pou, C., Garcia-Algas, F., de la Fuente, M.A., Juan, M., Tubau, A., Bachiller, D., Bernues, M. et al. (2007) Mutations in TBX1 genocopy the 22q11.2 deletion and duplication syndromes: a new susceptibility factor for mental retardation. Eur. J. Hum. Genet., 15, 658-663.
5. Zweier, C., Sticht, H., Aydin-Yaylagul, I., Campbell, C.E. and Rauch, A. (2007) Human TBX1 missense mutations cause gain of function resulting in the same phenotype as 22q11.2 deletions. Am. J. Hum. Genet., 80, 510-517.
6. Jerome, L.A. and Papaioannou, V.E. (2001) DiGeorge syndrome phenotype in mice mutant for the T-box gene, Tbx1. Nat. Genet., 27, 286-291.
7. Lindsay, E.A., Vitelli, F., Su, H., Morishima, M., Huynh, T., Pramparo, T., Jurecic, V., Ogunrinu, G., Sutherland, H.F., Scambler, P.J. et al. (2001) Tbx1 haploinsufficiency in the DiGeorge syndrome region causes aortic arch defects in mice. Nature, 410, 97-101.
8. Merscher, S., Funke, B., Epstein, J.A., Heyer, J., Puech, A., Lu, M.M., Xavier, R.J., Demay, M.B., Russell, R.G. and Factor, S. (2001) TBX1 is responsible for cardiovascular defects in velo-cardio-facial/DiGeorge syndrome. Cell, 104, 619-629.
9. Zhang, Z. and Baldini, A. (2008) In vivo response to high-resolution variation of Tbx1 mRNA dosage. Hum. Mol. Genet., 17, 150-157.
10. Vitelli, F., Huynh, T. and Baldini, A. (2009) Gain of function of Tbx1 affects pharyngeal and heart development in the mouse. Genesis, 47, 188-195.
11. Xu, H., Morishima, M., Wylie, J.N., Schwartz, R.J., Bruneau, B.G., Lindsay, E.A. and Baldini, A. (2004) Tbx1 has a dual role in the morphogenesis of the cardiac outflow tract. Development, 131, 3217-3227.
12. Zhang, Z., Huynh, T. and Baldini, A. (2006) Mesodermal expression of Tbx1 is necessary and sufficient for pharyngeal arch and cardiac outflow tract development. Development, 133, 3587-3595.
13. Liao, J., Aggarwal, V.S., Nowotschin, S., Bondarev, A., Lipner, S. and Morrow, B.E. (2008) Identification of downstream genetic pathways of Tbx1 in the second heart field. Dev. Biol., 316, 524-537.
14. Chen, L., Fulcoli, F.G., Tang, S. and Baldini, A. (2009) Tbx1 regulates proliferation and differentiation of multipotent heart progenitors. Circ. Res., 105, 842-851.
15. Vitelli, F., Taddei, I., Morishima, M., Meyers, E.N., Lindsay, E.A. and Baldini, A. (2002) A genetic link between Tbx1 and fibroblast growth factor signaling. Development, 129, 4605-4611.
16. Hu, T., Yamagishi, H., Maeda, J., McAnally, J., Yamagishi, C. and Srivastava, D. (2004) Tbx1 regulates fibroblast growth factors in the anterior heart field through a reinforcing autoregulatory loop involving forkhead transcription factors. Development, 131, 5491-5502.
17. Chen, L., Mupo, A., Huynh, T., Cioffi, S., Woods, M., Jin, C., McKeehan, W., Thompson-Snipes, L., Baldini, A. and Illingworth, E.A. (2010) Tbx1 regulates Vegfr3 and is required for lymphatic vessel development. J. Cell Biol., 189, 417-424.
18. Fulcoli, F.G., Huynh, T., Scambler, P.J. and Baldini, A. (2009) Tbx1 regulates the BMP-Smad1 pathway in a transcription independent manner. PLoS One, 4, e6049.
19. Massague, J., Seoane, J. and Wotton, D. (2005) Smad transcription factors. Genes Dev., 19, 2783-2810.
20. Chen, C.Y. and Schwartz, R.J. (1996) Recruitment of the tinman homolog Nkx-2.5 by serum response factor activates cardiac alpha-actin gene transcription. Mol. Cell. Biol., 16, 6372-6384.
21. Liu, N. and Olson, E.N. (2006) Coactivator control of cardiovascular growth and remodeling. Curr. Opin. Cell Biol., 18, 715-722.
22. Pollock, R. and Treisman, R. (1991) Human SRF-related proteins: DNA-binding properties and potential regulatory targets. Genes Dev., 5, 2327-2341.
23. Leifer, D., Krainc, D., Yu, Y.T., McDermott, J., Breitbart, R.E., Heng, J., Neve, R.L., Kosofsky, B., Nadal-Ginard, B. and Lipton, S.A. (1993) MEF2C, a MADS/MEF2-family transcription factor expressed in a laminar distribution in cerebral cortex. Proc. Natl Acad. Sci. USA, 90, 1546-1550.
24. Edmondson, D.G., Lyons, G.E., Martin, J.F. and Olson, E.N. (1994) Mef2 gene expression marks the cardiac and skeletal muscle lineages during mouse embryogenesis. Development, 120, 1251-1263.
25. Lyons, G.E., Micales, B.K., Schwarz, J., Martin, J.F. and Olson, E.N. (1995) Expression of mef2 genes in the mouse central nervous system suggests a role in neuronal maturation. J. Neurosci., 15, 5727-5738.
26. Lin, Q., Lu, J., Yanagisawa, H., Webb, R., Lyons, G.E., Richardson, J.A. and Olson, E.N. (1998) Requirement of the MADS-box transcription factor MEF2C for vascular development. Development, 125, 4565-4574.
27. Bi, W., Drake, C.J. and Schwarz, J.J. (1999) The transcription factor MEF2C-null mouse exhibits complex vascular malformations and reduced cardiac expression of angiopoietin 1 and VEGF. Dev. Biol., 211, 255-267.
28. Lin, Q., Schwarz, J., Bucana, C. and Olson, E.N. (1997) Control of mouse cardiac morphogenesis and myogenesis by transcription factor MEF2C. Science, 276, 1404-1407.
29. Monks, D.C. and Morrow, B.E. (2012) Identification of putative retinoic acid target genes downstream of mesenchymal Tbx1 during inner ear development. Dev. Dyn., 241, 563-573.
30. Huang da, W., Sherman, B.T. and Lempicki, R.A. (2009) Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat. Protoc., 4, 44-57.
31. Huang da, W., Sherman, B.T. and Lempicki, R.A. (2009) Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res., 37, 1-13.
32. Andres, V. and Walsh, K. (1996) Myogenin expression, cell cycle withdrawal, and phenotypic differentiation are temporally separable events that precede cell fusion upon myogenesis. J. Cell Biol., 132, 657-666.
33. Naya, F.J., Wu, C., Richardson, J.A., Overbeek, P. and Olson, E.N. (1999) Transcriptional activity of MEF2 during mouse embryogenesis monitored with a MEF2-dependent transgene. Development, 126, 2045-2052.
34. Wu, H., Naya, F.J., McKinsey, T.A., Mercer, B., Shelton, J.M., Chin, E.R., Simard, A.R., Michel, R.N., Bassel-Duby, R., Olson, E.N. and Williams, R.S. (2000) MEF2 responds to multiple calcium-regulated signals in the control of skeletal muscle fiber type. EMBO J., 19, 1963-1973.
35. Dodou, E., Verzi, M.P., Anderson, J.P., Xu, S.M. and Black, B.L. (2004) Mef2c is a direct transcriptional target of ISL1 and GATA factors in the anterior heart field during mouse embryonic development. Development, 131, 3931-3942.
36. Wang, D.Z., Valdez, M.R., McAnally, J., Richardson, J. and Olson, E.N. (2001) The Mef2c gene is a direct transcriptional target of myogenic bHLH and MEF2 proteins during skeletal muscle development. Development, 128, 4623-4633.
37. Takeuchi, J.K., Mileikovskaia, M., Koshiba-Takeuchi, K., Heidt, A.B., Mori, A.D., Arruda, E.P., Gertsenstein, M., Georges, R., Davidson, L., Mo, R. et al. (2005) Tbx20 dose-dependently regulates transcription factor networks required for mouse heart and motoneuron development. Development, 132, 2463-2474.
38. Garg, V., Kathiriya, I.S., Barnes, R., Schluterman, M.K., King, I.N., Butler, C.A., Rothrock, C.R., Eapen, R.S., Hirayama-Yamada, K., Joo, K. et al. (2003) GATA4 mutations cause human congenital heart defects and reveal an interaction with TBX5. Nature, 424, 443-447.
39. Linhares, V.L., Almeida, N.A., Menezes, D.C., Elliott, D.A., Lai, D., Beyer, E.C., Campos de Carvalho, A.C. and Costa, M.W. (2004) Transcriptional regulation of the murine Connexin40 promoter by cardiac factors Nkx2-5, GATA4 and Tbx5. Cardiovasc. Res., 64, 402-411.
40. Saga, Y., Miyagawa-Tomita, S., Takagi, A., Kitajima, S., Miyazaki, J. and Inoue, T. (1999) MesP1 is expressed in the heart precursor cells and required for the formation of a single heart tube. Development, 126, 3437-3447.
41. Angelini, C., Cutillo, L., De Canditiis, D., Mutarelli, M. and Pensky, M. (2008) BATS: a Bayesian user-friendly software for analyzing time series microarray experiments. BMC Bioinformatics, 9, 415; doi:10.1186/ 1471-2105-9-415.
42. Livak, K.J. and Schmittgen, T.D. (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods, 25, 402-408.
43. Schmittgen, T.D. and Livak, K.J. (2008) Analyzing real-time PCR data by the comparative C(T) method. Nat. Protoc., 3, 1101-1108.
44. Wilkinson, D.G. (1992) Whole-mount in situ hybridization of vertebrate embryos. In Situ Hybridization: A Practical Approach. IRL Press, Oxford, UK, pp. 75-83.
45. Wu, Y., Zhang, X., Salmon, M., Lin, X. and Zehner, Z.E. (2007) TGFbeta1 regulation of vimentin gene expression during differentiation of the C2C12 skeletal myogenic cell line requires Smads, AP-1 and Sp1 family members. Biochim. Biophys. Acta, 1773, 427-439.
46. Chakrabarti, S.K., James, J.C. and Mirmira, R.G. (2002) Quantitative assessment of gene targeting in vitro and in vivo by the pancreatic transcription factor, Pdx1. Importance of chromatin structure in directing promoter binding. J. Biol. Chem., 277, 13286-13293.